Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Elosulfase_alfa> ?p ?o. }
Showing items 1 to 22 of
22
with 100 items per page.
- Elosulfase_alfa abstract "Elosulfase alfa (Vimizim) is a drug for the treatment of Morquio syndrome which is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfatase. Elosulfase alfa is a synthetic version of this enzyme.Elsuflase alfa was developed by BioMarin Pharmaceutical Inc. and approved for use in the US by the Food and Drug Administration in 2014.".
- Elosulfase_alfa casNumber "9025-60-9".
- Elosulfase_alfa wikiPageID "42240797".
- Elosulfase_alfa wikiPageRevisionID "604256681".
- Elosulfase_alfa c "5020".
- Elosulfase_alfa casNumber "9025".
- Elosulfase_alfa h "7588".
- Elosulfase_alfa molecularWeight "110.8".
- Elosulfase_alfa n "1364".
- Elosulfase_alfa o "1418".
- Elosulfase_alfa s "34".
- Elosulfase_alfa tradename "Vimizim".
- Elosulfase_alfa subject Category:Peptides.
- Elosulfase_alfa type Drug.
- Elosulfase_alfa type FunctionalSubstance.
- Elosulfase_alfa comment "Elosulfase alfa (Vimizim) is a drug for the treatment of Morquio syndrome which is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfatase. Elosulfase alfa is a synthetic version of this enzyme.Elsuflase alfa was developed by BioMarin Pharmaceutical Inc. and approved for use in the US by the Food and Drug Administration in 2014.".
- Elosulfase_alfa label "Elosulfase alfa".
- Elosulfase_alfa sameAs m.0100rzm8.
- Elosulfase_alfa sameAs Q17119086.
- Elosulfase_alfa sameAs Q17119086.
- Elosulfase_alfa wasDerivedFrom Elosulfase_alfa?oldid=604256681.
- Elosulfase_alfa isPrimaryTopicOf Elosulfase_alfa.